SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-002868
Filing Date
2013-11-08
Accepted
2013-11-08 11:20:08
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agen-9302013x10q.htm 10-Q 624174
2 CERTIFICATION OF PEO PURSUANT TO SECTION 302 agen-exhibit311q313.htm EX-31.1 13899
3 CERTIFICATION OF PFO PURSUANT TO SECTION 302 agen-exhibit312q313.htm EX-31.2 13395
4 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 agen-exhibit321q313.htm EX-32.1 9049
  Complete submission text file 0001445305-13-002868.txt   3677129

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT agen-20130930.xml EX-101.INS 361528
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agen-20130930.xsd EX-101.SCH 28234
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agen-20130930_cal.xml EX-101.CAL 43610
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agen-20130930_def.xml EX-101.DEF 141886
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agen-20130930_lab.xml EX-101.LAB 421904
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agen-20130930_pre.xml EX-101.PRE 236156
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 131203181
SIC: 2836 Biological Products, (No Diagnostic Substances)